Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia

We describe two cases of pulmonary arterial hypertension (PAH) that occurred under dasatinib treatment and were resolved after dasatinib discontinuation. Two patients with chronic phase chronic myeloid leukemia (CML) were switched to dasatinib therapy because of hematological progress while receivin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Ji Hyung, Lee, Sung-Eun, Choi, Soo Young, Kim, Soo-Hyun, Jang, Eun-Jung, Bang, Ju-Hee, Park, Jin Eok, Jeon, Hye-Rim, Oh, Yun Jeong, Yi, Jeong-Eun, Jung, Hae Ok, Youn, Ho Joong, Kim, Dong-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614213/
https://www.ncbi.nlm.nih.gov/pubmed/25648097
http://dx.doi.org/10.4143/crt.2013.155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4614213/
https://www.ncbi.nlm.nih.gov/pubmed/25648097
http://dx.doi.org/10.4143/crt.2013.155

Ejemplares similares